A Missouri overview of physician-supervised GLP-1 treatment through Astra, including local access context and the cities we cover. Every statistic on this page links to its source.
More than one in three adults in Missouri — 34.6% — live with obesity, according to the CDC's 2024 Behavioral Risk Factor Surveillance System (BRFSS) survey of the state's adult population 1. Missouri is home to about 6,245,466 residents (U.S. Census Bureau, Vintage 2024 population estimate) 2.
That combination — high prevalence, thin specialist coverage — is what makes the state's coverage rules and its telehealth access options matter.
Missouri Medicaid (MO HealthNet) does cover GLP-1 medications for obesity — but narrowly, and by drug name. Under Prior Authorization Form 2575-053, "GLP-1 Receptor Agonists for All Indications" (revised April 2026), MO HealthNet's preferred obesity agents are Zepbound (tirzepatide) and Foundayo (orforglipron). A member qualifies by meeting one of five criteria: age 18+ with a BMI of 30 or higher; age 18+ with a BMI of 27 or higher plus a weight-related comorbidity; age 12–17 with a BMI at or above the 95th percentile for age and sex; concurrent antipsychotic therapy; or noncirrhotic MASH with F2/F3 liver fibrosis, confirmed by biopsy or a noninvasive test. Patients already taking Zepbound before enrolling in MO HealthNet must document their starting and current BMI along with three recent fill dates to continue coverage 5.
Wegovy (semaglutide) is explicitly excluded on the same form — in bold — for "reduction of excess body weight or maintenance of weight reduction long term." MO HealthNet pays for Wegovy only for two non-obesity indications: MACE (major cardiovascular event) risk reduction in non-diabetic adults 45 and older with a BMI of 27+ and a qualifying cardiovascular diagnosis, or noncirrhotic MASH with F2/F3 fibrosis — and even then, the initial approval is capped at four weeks, with renewal required at every dose increase. Non-preferred diabetes-labeled GLP-1s (Bydureon BCise, exenatide, generic liraglutide, Rybelsus, Soliqua, Xultophy) require a documented three-month trial of three preferred agents first 5.
The practical read: Missouri Medicaid is a real payer for obesity-indicated GLP-1s, but only through Zepbound or orforglipron, only for members who clear specific BMI-and-comorbidity criteria, and not at all for semaglutide prescribed simply for weight loss 5.
What GLP-1 care costs in Missouri today is largely a function of which door a patient walks through. Members who qualify under MO HealthNet's criteria above pay Medicaid cost-sharing for Zepbound or orforglipron; nearly everyone else — including anyone Medicaid excludes from Wegovy coverage, and the roughly 7.7% of Missourians who carry no health insurance at all (474,886 of 6,143,552 residents, ACS 2024 1-Year Estimate) — is paying cash 4.
Astra's pricing is the same for every patient in every state: $68/month for semaglutide and $118/month for tirzepatide, billed on a 12-month plan ($816 and $1,416 paid annually). There is no Missouri-specific price, discount, or surcharge — the number is identical whether a patient is in St. Louis, Springfield, or anywhere else in the state.
Access to the physicians who prescribe and manage these medications is uneven across the state. As of December 31, 2025, Missouri had 344 federally designated Primary Care Health Professional Shortage Areas, covering roughly 1,837,226 residents — about 29% of the state's population — where only 21.5% of primary care need is currently met (HRSA HPSA Quarterly data, via KFF State Health Facts) 3. HRSA estimates the state would need 475 additional primary-care practitioners to lift every one of those areas out of shortage status 3.
For a resident in one of those areas, a same-week visit with a physician willing to evaluate and prescribe a GLP-1 is often the practical bottleneck — not the medication itself, and not, for most patients, insurance. Telehealth doesn't eliminate the underlying shortage, but it does remove the requirement to physically reach a clinic that has an opening.
Missouri's telehealth prescribing rules for physicians are set by the Missouri State Board of Registration for the Healing Arts 6. TODO: this pack has not independently verified Missouri's specific telehealth-prescribing requirements for GLP-1 medications (e.g., any in-person-exam or established-relationship rule beyond standard telemedicine practice-act provisions) — confirm directly with the Board before publishing any claim more specific than "Missouri-licensed prescribers can treat Missouri patients by telehealth," and update this note once confirmed.
Astra is licensed to treat patients in all 50 states, including Missouri. There is no waitlist tied to geography and no state-specific version of the program — a Missouri patient gets the same clinicians, the same medications, and the same $68/$118 monthly pricing as a patient anywhere else Astra operates.
Astra treats patients in Missouri through state-licensed physicians.
Springfield's city page carries local coverage, access, and pricing detail.
Yes, but narrowly. MO HealthNet covers Zepbound (tirzepatide) and Foundayo (orforglipron) for obesity if a member meets specific BMI-and-comorbidity criteria (PA Form 2575-053, rev. April 2026). Wegovy (semaglutide) is explicitly excluded for straightforward weight loss and is covered only for two narrow cardiovascular- or liver-related indications, each capped and closely reviewed. Members outside those criteria pay cash, as most privately-insured and uninsured Missourians already do.
Yes. Astra is licensed in all 50 states, including Missouri, with no separate waitlist or state-specific program.
We haven't published a verified, sourced price index of Missouri clinics to compare against — that's a data gap, not a guess, and we won't estimate a number we can't cite. What we can say precisely: Astra's price doesn't change by location. It's $68/month for semaglutide and $118/month for tirzepatide on a 12-month plan everywhere Astra operates, including Missouri. If you find a lower verified cash price at a specific Missouri clinic, compare it directly — we'd rather you have the real number than a marketing claim.
Missouri has 344 federally designated primary-care shortage areas covering about 1.84 million residents, where only 21.5% of care need is met (HRSA, as of Dec. 31, 2025). In those areas, the bottleneck to starting a GLP-1 is often getting an appointment with a prescriber at all — something telehealth addresses directly.
Missouri's telehealth practice rules for physicians are set by the Missouri State Board of Registration for the Healing Arts. We link to the Board directly on this page; if you have a rule-specific question this page doesn't cover, that's a sign the rule still needs verification — check with the Board or your prescriber directly.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.